Launch of the 2018 Open Accelerator programme: 11 participants selected

ottobre 2018

Milan, October 2018 - A sphere to reduce Parkinsonian tremors; a device for the early detection of respiratory diseases; sensors that transform the current inhalers into smart connected devices.... These are just some of the solutions devised by the teams participating in the third edition of Open Accelerator (OA), the international acceleration programme in the field of Life Sciences initiated by Zcube, Research Venture of the Zambon pharmaceutical group.

Thanks to a structured and rigorous process involving experts, advisors, key opinion leaders and investors, 11 projects were selected from the 78 applications received in response to the call for projects 2018 which for the first time focused specifically on the therapeutic areas of the Central Nervous System and the Respiratory System and on the following technologies: Wearable and Digital Health, Big Data, Medical Devices, Biomarkers and Diagnostics and Drug Delivery Systems.

Eleven international teams will participate in the acceleration programme launched on September 14th together with Deloitte's Officine Innovazione and with the support of the initiative's partners: Italian Angels for Biotech, Innogest, Premio Marzotto, Unicredit, StartLab, Bird & Bird legal firm.

  1. Lung Passport (Minsk, Belarus)
  2. Mobile GaitLab (N├╝rnberg, Germany)
  3. Amiko (London, United Kingdom)
  4. Vilim ball (Kaunas, Lithuania)
  5. TherA (Berlin, Germany)
  6. ParkinTest (Varese, Italy)
  7. First blood test for multiple sclerosis by Prindex (Naples, Italy)
  8. RT 100, a Metered Dose Inhaler Pump (Brescia, Italy)
  9. SPYRAS (London, United Kingdom)
  10. Development of a nano-sensor multiprobe device in optical fibre (Naples, Italy)
  11. DIAGNOS (Cameroon)

Aimed at encouraging further development of the projects, the Open Accelerator programme will run until the end of November and includes a mix of on-site sessions at the OpenZone scientific campus near Milan (Bresso) and online, customised for the various startups. The backbone of the programme is the robust mentorship of various experts (at least four for each startup) sharing their scientific and business skills.

At the end of the programme the best startups will have the opportunity to receive a seed investment up to a maximum of 100,000 euros (per project) and to start a strategic partnership with Zambon.


###

About Zcube
Zcube, Zambon Research Venture, is the division that actively deals with innovation, scouting for modern health solutions in the field of Life Sciences, such as drug delivery systems, medical devices, biomarkers, diagnostic, digital health and big data solutions. Recognizing the ever-growing importance of innovative technologies and the digitalization of healthcare - thanks to Zcube activities - Zambon complements the offering of medicines with modern health solutions, in order to provide comprehensive high quality solutions to patients.
Zcube is made of three units: ZCare, Open Accelerator and OpenZone.

  • ZCare develops HI-tech & HI-touch integrated solutions to transform the disease management into a caring experience.
  • Open Accelerator is the international fast track acceleration program dedicated to projects in life sciences, with a specific focus on Central Nervous System (CNS) and Respiratory diseases.
  • OpenZone is the Life Sciences Campus on the outskirts of Milan created by Zambon as a fundamental part of its Open Innovation philosophy. OpenZone currently is home to over 22 organizations working in the Life Sciences field, and a visionary development plan will double its spaces by 2020.

 

Per maggiori informazioni:

Federica Alberti
Cell +39 348 2806618
Tel +39 02 66524732
Email: federica.alberti@zambongroup.com


Press release